Although it has been reported that alterations in METTL3 modulate the osteogenic lineage commitment and differentiation of BMSCs and are involved in osteoporosis [27], the role of m6A modification in osteoblast differentiation in an inflammatory environment remains unclear. The gene discussed is METTL3; the disease is osteoporosis.